Rivastigmine tartrate
Rivastigmine tartrate is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

Catalog Number | T1628 |
Alternative Name(s) | SDZ-ENA 713 , ENA 713 |
Research Area | Neuroscience |
Molecular Formula | C14H22N2O2·C4H6O6 |
CAS# | 129101-54-8 |
Purity | 99.66% |
SMILES | O[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C |
Size | 50 mg |
Supplier Page | https://www.targetmol.com/compound/Rivastigmine tartrate |
Additional Information | https://www.targetmol.com/datasheet/T1628 |